Bio Techne | TECH - 销售收入



金融业
股票价格
USD
资产
USD 2.59B
现金及等价物
USD 264.71M
销售成本
USD 103.13M
流动资产
USD 744.4M
流动负债
USD 163.7M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 115.94M
员工
3.1K
EPS每股收益
USD 0.52
股本和储备
USD 2.11B
销售毛利
USD 222.15M
债务利息支出
USD 3.6M
利息收入
USD 981K
贷款资金
USD 200M
市值
USD 11.35B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 106.09M
销售收入
USD 321.2M
销售和管理费用
USD 109.34M
股票
USD 195.74M
贸易债权人
USD 26.7M
应收帐款人
USD 214.56M


销售 更改 日
Agilent USD 1.88B 43M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Bio Techne USD 321.2M 9.8M 2026-06
Bio-Rad Laboratories USD 651M 58.9M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Danaher USD 6.3B 350M 2026-06
Illumina USD 1.16B 70M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Merck EUR 5.43B 300M 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Repligen USD 204M 10M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Standard Biotools USD 21.1M 2.7M 2026-03
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Waters USD 1.64B 370M 2026-06